TAK

NYSE 已收盘

Takeda Pharmaceutical Company

21.41 USD
▲+0.14+0.66%
盘后 21.87 +2.15%
2026-11-19
市值
$71.19B
市盈率
269.80
EPS
0.08
股息率
1.10%
52 周区间
14.01 – 21.86
成交量
5.54M
Beta
0.08
目标价
24.65
52W 低 14.0152W 高 21.86
价格走势

公司简介

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enan...

关联新闻